Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.
Ahn DH, Ridinger M, Cannon TL, Mendelsohn L, Starr JS, Hubbard JM, Kasi A, Barzi A, Samuëlsz E, Karki A, Subramanian RA, Yemane D, Kim R, Wu CC, Croucher PJP, Smeal T, Kabbinavar FF, Lenz HJ.
Ahn DH, et al. Among authors: subramanian ra.
J Clin Oncol. 2024 Oct 30:JCO2401266. doi: 10.1200/JCO-24-01266. Online ahead of print.
J Clin Oncol. 2024.
PMID: 39475591